ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

EVOK Evoke Pharma Inc

0.4351
0.0031 (0.72%)
May 28 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 21,364
Bid Price 0.3905
Ask Price 0.47
News -
Day High 0.4548

Low
0.40

52 Week Range

High
1.96

Day Low 0.40
Company Name Stock Ticker Symbol Market Type
Evoke Pharma Inc EVOK NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.0031 0.72% 0.4351 18:00:01
Open Price Low Price High Price Close Price Prev Close
0.454 0.40 0.4548 0.4351 0.432
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
140 21,364 $ 0.4480791 $ 9,573 - 0.40 - 1.96
Last Trade Time Type Quantity Stock Price Currency
19:57:51 2 $ 0.47 USD

Evoke Pharma Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
3.73M 8.48M - 5.18M -7.79M -0.92 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Evoke Pharma News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No EVOK Message Board. Create One! See More Posts on EVOK Message Board See More Message Board Posts

Historical EVOK Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.480.550.400.455822493,824-0.0449-9.35%
1 Month0.4470.550.400.460793634,563-0.0119-2.66%
3 Months0.640.760.400.556090935,006-0.2049-32.02%
6 Months1.271.450.400.704795942,955-0.8349-65.74%
1 Year1.731.960.400.960625431,605-1.29-74.85%
3 Years1.265.960.22611.12570,672-0.8249-65.47%
5 Years0.586.06280.22611.70559,367-0.1449-24.98%

Evoke Pharma Description

Evoke Pharma Inc is a specialty pharmaceutical company focused on the development of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.